SEC Form 4 · accession 0001230584-26-000006
AtriCure, Inc. · ATRC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael H Carrel
Officer — President, CEO, & Director · Director
Period of report
Jun 30, 2026
Accepted (ET)
Jul 2, 2026 · 9:06 am EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001323885
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Jun 30, 2026 | A | 636 | $23.78 | A | 779,134 | D | |
| Common StockF3 | holding | — | — | — | 14,310 | I | Held by reporting person's children | |
| Common StockF3 | holding | — | — | — | 2,250 | I | Held by reporting person's parents | |
| Common StockF3 | holding | — | — | — | 1,000 | I | Held by reporting person's sibling |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares acquired pursuant to the AtriCure, Inc. 2018 Employee Stock Purchase Plan for the period ended June 30, 2026.
- F2In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on June 30, 2026, which is the last trading day of the applicable offering period. The closing price on June 30, 2026, was $27.98.
- F3The reporting person disclaims beneficial ownership of these securities, except as to his pecuniary interest therein.